HK2 and neoplasm: 3-BP, a halogenated analog of pyruvate, has emerged as a promising anti-tumor agent due to its selective inhibition of critical glycolysis enzymes including HK2, GAPDH, and 3-PGK, thus reducing ATP production and causing cancer cell death (160, 161).